Deutsche Bank: Vertex Pharma's Disappointing VX-661 Trial Results Isn't The End
March 23, 2015 at 19:03 PM EDT
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares sank Monday on results from a trial of one of its cystic fibrosis ...
